Proposed Rule Limits Gender-Affirming Care in U.S. Hospitals

Last Thursday, the Trump administration introduced a proposed rule that would significantly restrict access to gender-affirming care for minors in hospitals receiving Medicare or Medicaid funding. Under this rule, hospitals would be prohibited from providing such care, even if patients are privately insured or can self-fund their treatment. This move raises concerns about the implications for healthcare access across the United States.

The proposed regulation categorizes gender-affirming procedures as “sex-rejecting procedures” (SRPs) and adds a new condition of participation for hospitals. This condition would prevent any Medicare-participating hospital from offering these services to underage patients, a measure that may also indirectly affect Medicaid reimbursement since many hospitals qualify for Medicaid by adhering to Medicare standards.

The Medicare and Medicaid programs, established in 1965, were designed to provide essential health services while ensuring that the federal government would not interfere in medical practice. The Medicare Act explicitly prohibits federal officials from exercising control over how medical services are delivered. This was intended to reassure physicians concerned about government overreach in patient care decisions.

Wilbur Cohen, a key architect of the Medicare and Medicaid programs, emphasized in 1985 that the prohibition against federal interference was crucial in countering opposition to the legislation. According to the Act, while the Centers for Medicare and Medicaid Services (CMS) can set certain requirements for hospitals, it cannot mandate specific treatments that physicians must offer or withhold.

The proposed rule has sparked significant debate regarding its potential impact on healthcare delivery. If finalized, it could have a chilling effect on hospitals’ willingness to provide gender-affirming care, particularly as Medicare and Medicaid payments account for nearly half of hospital reimbursements. Hospitals that choose to continue offering these services may face financial challenges, putting their viability at risk and potentially leading to closures that would affect community health.

Many argue that the proposed rule represents an overreach by CMS, as it seeks to redefine what constitutes medical care by labeling gender-affirming procedures as non-medical. Critics assert that this could set a dangerous precedent, allowing the federal government to exert influence over medical practices beyond gender-affirming care. The implications could extend to other areas of healthcare, including reproductive health services and vaccinations, which have also faced political scrutiny.

The public has a window of 60 days to provide feedback on the proposed rule, which CMS must consider before finalizing any regulations. Legal challenges are anticipated if the rule is implemented, although litigation can be a lengthy process. The proposed changes could ultimately limit the ability of patients and physicians to make collaborative decisions regarding appropriate healthcare.

Carmel Shachar, J.D., M.P.H., an assistant clinical professor at Harvard Law School, and Nicole Huberfeld, Edward R. Utley professor of health law at Boston University, have noted the potential ramifications of this rule on patient care. They warn that if the rule is adopted, it could hinder the relationship between patients and healthcare providers by shifting decision-making power to the federal government.

As discussions continue, the healthcare community watches closely to see how this ruling could reshape the landscape of medical practice and the availability of gender-affirming care in the United States.